Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

New study uses sleep monitoring and AI to detect Alzheimer's

22

Jul 2026

New study uses sleep monitoring and AI to detect Alzheimer's

Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer's.

Global hunger declines for third straight year but remains fragile, report reveals

22

Jul 2026

Global hunger declines for third straight year but remains fragile, report reveals

Global hunger declined for a third consecutive year in 2025, demonstrating that progress is possible. However, the improvements remain fragile, unevenly distributed and insufficient to achieve the Sustainable Development Goals by 2030, according to The State of Food Security and Nutrition in the World 2026 (SOFI 2026) report, released on Tuesday by five United Nations specialized agencies.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.